The University of New South Wales (UNSW) was awarded a $5,835,803 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on March 1, 2025, supports the development of "The Breast Cancer Cellular Atlas" - an innovative research project aimed at advancing the scientific understanding and treatment of breast cancer. As a leading Australian research institution, UNSW will leverage its expertise in fields like biology, materials science, and information technology to conduct comprehensive investigations into the cellular mechanisms underlying breast cancer. The project is scheduled for completion by February 28, 2029. This federal grant award represents UNSW's ongoing collaboration with various U.S. government agencies, including the Department of Defense and National Institutes of Health, in conducting impactful biomedical research to benefit military personnel, veterans, and the broader public.
Generated 3/4/25, 7:47 AM